TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

TELA Bio, Inc.

We are focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. We are committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials.

Please see our social media community guidelines at http://bit.ly/1UVcx0L

MidCap Financial

Essex Woodlands Healthcare Partners

Checkmate Capital

Signet Healthcare Partners

OrbiMed

Pacira Pharmaceuticals

Quaker Partners

ProMedica Health System

TELA Bio

One portfolio with a variety of options. Learn all about the OviTex PRS portfolio here! https://hubs.li/Q02kn7XN0! 
#TELABio #OviTexPRS #PlasticSurgery #ReconstructiveSurgery

Stop by table 17 at the American-Brazilian Aesthetics Meeting to talk to the TELA Bio team about our latest technology! Discover even more at https://hubs.li/Q02jDzkJ0
#OviTexPRS #Aesthetics #ABAM

Are you attending #ABAM in Park City, UT? Visit table 17 to learn about the only reinforced biologic for plastic and reconstructive surgery, OviTex PRS! Visit https://hubs.li/Q02jQGC40 for more! #OviTexPRS #Aesthetics

Did you know… OviTex PRS provides the right support for every stage of you repair? Learn how it compares to your ADM here https://hubs.li/Q02jSThx0. #OviTexPRS #ADM

Thank you to everyone who joined us at the Foundation for Research and Education in Esophageal and Foregut Disease meeting in Hawaii! We hope you enjoyed learning about the benefits of OviTex Reinforced Tissue Matrix! Learn even more at https://hubs.ly/Q02k09dJ0. #OviTex #TELABio

OviTex Reinforced Tissue Matrix provides a portfolio of solutions that are available in permanent or resorbable reinforcement. Learn about all of the reasons why we recommend OviTex below! Visit https://hubs.li/Q02jDp390 for more! #HerniaRepair

We continue to review and study new products that provide better outcomes with less cost to patients and health systems. This is a case study providing an alternative to biologics for contaminated abdominal closures. Thank you Luis Fernandez for allowing me to participate.

The trauma and surgery departments at UT Health are doing great things for our community!

We would like to express our thanks to Professor Miguel Angel Garcia Urena, Dr. Bob Bloemendaal, Mr. Alastair Windsor, Mr. David Ross, esteem faculty and the Mark Allen Group for an excellent #AWRE2024. See you all in 2025! #TELABio

On day 2 at #AWRE2024 Professor Miguel Angel Garcia Urena and Dr. Bob Bloemendaal presented on “Open and Robotic Pauli Parastomal Hernia Repairs with OviTex Reinforced Tissue Matrix”. We had a great turnout! #TELABio

We are 15 minutes away! If you are attending the Updates in General Surgery Meeting visit Saloon B at 6AM to learn about innovations in parastomal hernia repair techniques! Visit www.telabio.com for more information.  #UpdatesinGeneralSurgery #BreakfastSymposium

NASDAQ:TELA

TELA Bio

Last Close

2.93

30/08 20:00

Market Cap

111.20M

Beta: 0.97

Volume Today

28.25K

Avg: 55.51K

PE Ratio

−3.58

PFCF: −4.83

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics